Regulation of catabolic gene expression in normal and degenerate human intervertebral disc cells: implications for the pathogenesis of intervertebral disc degeneration

IntroductionThe aim of this study was to compare the effects of tumour necrosis factor-alpha (TNF-α) and interleukin-1-beta (IL-1β) on protease and catabolic cytokine and receptor gene expression in normal and degenerate human nucleus pulposus cells in alginate culture.MethodsCells isolated from normal and degenerate nucleus pulposus regions of human intervertebral discs were cultured in alginate pellets and stimulated by the addition of 10 ng/mL TNF-α or IL-1β for 48 hours prior to RNA extraction. Quantitative real-time polymerase chain reaction was used to assess the effect of TNF-α or IL-β stimulation on the expression of matrix metalloproteinase (MMP)-3, -9 and -13, TNF-α, TNF receptor 1 (TNF-R1), TNF receptor 2 (TNF-R2), IL-1α, IL-1β, IL-1 receptor 1 (IL-1R1) and IL-1 receptor antagonist (IL-1Ra).ResultsMMP-3 and MMP-9 gene expressions were upregulated to a greater level by IL-1β than TNF-α. MMP-13 was upregulated by each cytokine to a similar extent. TNF-α and TNF-R2 expressions were upregulated by both TNF-α and IL-β, whereas TNF-R1 expression was not significantly affected by either cytokine. IL-1β and IL-1Ra expressions were significantly upregulated by TNF-α, whereas IL-1α and IL-1R1 were unchanged.ConclusionsTNF-α does not induce MMP expression to the same degree as stimulation by IL-1β, but it does act to upregulate IL-1β expression as well as TNF-α and TNF-R2. The net result of this would be an increased inflammatory environment and accelerated degradation of the matrix. These results support the hypothesis that, while TNF-α may be an important initiating factor in matrix degeneration, IL-1β plays a greater role in established pathological degradation.

[1]  D. Polly,et al.  Surgical Treatment for the Painful Motion Segment: Matching Technology With the Indications: Posterior Lumbar Fusion , 2005, Spine.

[2]  P. Roux‐Lombard,et al.  Dysregulation of the in vivo production of interleukin-1 receptor antagonist in patients with rheumatoid arthritis. Pathogenetic implications. , 1995, Arthritis and rheumatism.

[3]  T. Mak,et al.  Collagen-induced arthritis in TNF receptor-1-deficient mice: TNF receptor-2 can modulate arthritis in the absence of TNF receptor-1. , 2001, Clinical immunology.

[4]  M. Feldmann,et al.  INHIBITORY EFFECT OF TNFα ANTIBODIES ON SYNOVIAL CELL INTERLEUKIN-1 PRODUCTION IN RHEUMATOID ARTHRITIS , 1989, The Lancet.

[5]  J. Dayer,et al.  Inhibition of the production and effects of interleukins‐1 and tumor necrosis factor α in rheumatoid arthritis , 1995 .

[6]  G. R. Dodge,et al.  Effects of interleukin-1β and tumor necrosis factor-α on expression of matrix-related genes by cultured equine articular chondrocytes , 2000 .

[7]  N. Boos,et al.  Expression and Distribution of Tumor Necrosis Factor Alpha in Human Lumbar Intervertebral Discs: A Study in Surgical Specimen and Autopsy Controls , 2005, Spine.

[8]  A. Freemont,et al.  The role of interleukin-1 in the pathogenesis of human Intervertebral disc degeneration , 2005, Arthritis research & therapy.

[9]  N. Boos,et al.  Analysis of tissue distribution of TNF-alpha, TNF-alpha-receptors, and the activating TNF-alpha-converting enzyme suggests activation of the TNF-alpha system in the aging intervertebral disc. , 2007, Annals of the New York Academy of Sciences.

[10]  M. Nagino,et al.  Phosphorylation of extracellular signal‐regulated kinase 1/2, p38 mitogen‐activated protein kinase and nuclear translocation of nuclear factor‐κB are involved in upregulation of matrix metalloproteinase‐9 by tumour necrosis factor‐α , 2009, Liver international : official journal of the International Association for the Study of the Liver.

[11]  M. Feldmann,et al.  Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[12]  J. Dayer,et al.  Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis. , 1995, Arthritis and rheumatism.

[13]  J. Hoyland,et al.  Human disc degeneration is associated with increased MMP 7 expression , 2006, Biotechnic & histochemistry : official publication of the Biological Stain Commission.

[14]  A. Freemont,et al.  Catabolic cytokine expression in degenerate and herniated human intervertebral discs: IL-1β and TNFα expression profile , 2007, Arthritis research & therapy.

[15]  Max Aebi,et al.  Immunolocalization of major interstitial collagen types in human lumbar intervertebral discs of various ages , 1998, Virchows Archiv.

[16]  P. Roughley,et al.  Tumor Necrosis Factor&agr; Modulates Matrix Production and Catabolism in Nucleus Pulposus Tissue , 2005, Spine.

[17]  A. Freemont,et al.  Matrix synthesis and degradation in human intervertebral disc degeneration. , 2007, Biochemical Society transactions.

[18]  A. Freemont,et al.  Interleukin-1 receptor antagonist delivered directly and by gene therapy inhibits matrix degradation in the intact degenerate human intervertebral disc: an in situ zymographic and gene therapy study , 2007, Arthritis research & therapy.

[19]  A. Nachemson,et al.  Factors involved in the nutrition of the human lumbar intervertebral disc: cellularity and diffusion of glucose in vitro. , 1975, Journal of anatomy.

[20]  L. Joosten,et al.  Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: a comparative study using anti-TNFalpha, anti-IL-1alpha/beta and IL-1Ra. , 1996 .

[21]  M. Tortorella,et al.  The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation. , 2001, Osteoarthritis and cartilage.

[22]  R. Kinne,et al.  Preferential induction of prodestructive matrix metalloproteinase-1 and proinflammatory interleukin 6 and prostaglandin E2 in rheumatoid arthritis synovial fibroblasts via tumor necrosis factor receptor-55. , 2003, The Journal of rheumatology.

[23]  L. Setton,et al.  Intervertebral Disc Cells Exhibit Differences in Gene Expression in Alginate and Monolayer Culture , 2001, Spine.

[24]  F. Nielsen,et al.  Diverging mechanisms for TNF‐α receptors in normal mouse brains and in functional recovery after injury: From gene to behavior , 2007, Journal of neuroscience research.

[25]  N. Boos,et al.  2002 SSE Award Competition in Basic Science: Expression of major matrix metalloproteinases is associated with intervertebral disc degradation and resorption , 2002, European Spine Journal.

[26]  A. Freemont,et al.  Investigation of the role of IL-1 and TNF in matrix degradation in the intervertebral disc. , 2008, Rheumatology.

[27]  V. Lefebvre,et al.  Production of gelatin-degrading matrix metalloproteinases ('type IV collagenases') and inhibitors by articular chondrocytes during their dedifferentiation by serial subcultures and under stimulation by interleukin-1 and tumor necrosis factor alpha. , 1991, Biochimica et biophysica acta.

[28]  A. Gray,et al.  The economic burden of back pain in the UK , 1999, Pain.

[29]  G. R. Dodge,et al.  Effects of interleukin-1beta and tumor necrosis factor-alpha on expression of matrix-related genes by cultured equine articular chondrocytes. , 2000, American Journal of Veterinary Research.

[30]  A. Freemont,et al.  Expression of chondrocyte markers by cells of normal and degenerate intervertebral discs , 2002, Molecular pathology : MP.

[31]  A. Freemont,et al.  A preliminary in vitro study into the use of IL‐1Ra gene therapy for the inhibition of intervertebral disc degeneration , 2006, International journal of experimental pathology.

[32]  N. Boos,et al.  Analysis of Tissue Distribution of TNF‐α, TNF‐α‐Receptors, and the Activating TNF‐α–Converting Enzyme Suggests Activation of the TNF‐α System in the Aging Intervertebral Disc , 2007 .

[33]  A. Freemont,et al.  Localization of degradative enzymes and their inhibitors in the degenerate human intervertebral disc , 2004, The Journal of pathology.

[34]  S. Jang,et al.  mRNA Expression of Cytokines and Chemokines in Herniated Lumbar Intervertebral Discs , 2002, Spine.

[35]  H. Towbin,et al.  Neutralization of interleukin-1 beta activity in vivo with a monoclonal antibody alleviates collagen-induced arthritis in DBA/1 mice and prevents the associated acute-phase response. , 1993, Clinical and experimental rheumatology.

[36]  L. Joosten,et al.  Amelioration of established murine collagen‐induced arthritis with anti‐IL‐1 treatment , 1994, Clinical and experimental immunology.